Clarius Group, LLC Zoetis Inc. Transaction History

Clarius Group, LLC

$1.4 Billion
Q3 2024

A detailed history of Clarius Group, LLC transactions in Zoetis Inc. stock. As of the latest transaction made, Clarius Group, LLC holds 4,293 shares of ZTS stock, worth $706,627. This represents 0.06% of its overall portfolio holdings.

Number of Shares

4,293

Previous 4,446 3.44%

Holding current value

$706,627

Previous $770,000 8.83%

% of portfolio

0.06%

Previous 0.06%

22 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 09, 2024	SELL	$172.58 - $196.48 $26,404 - $30,061	-153 Reduced 3.44%	4,293 $838,000
Q2 2024 Jul 11, 2024	SELL	$145.54 - $178.83 $84,558 - $103,900	-581 Reduced 11.56%	4,446 $770,000
Q1 2024 Apr 17, 2024	SELL	$165.67 - $199.94 $81,675 - $98,570	-493 Reduced 8.93%	5,027 $850,000
Q4 2023 Jan 29, 2024	SELL	$151.44 - $200.09 $119,789 - $158,271	-791 Reduced 12.53%	5,520 $1.09 Million
Q3 2023 Oct 19, 2023	SELL	$167.14 - $192.77 $329,934 - $380,527	-1,974 Reduced 23.83%	6,311 $1.1 Million
Q2 2023 Aug 09, 2023	BUY	$160.94 - $186.23 $18,347 - $21,230	114 Added 1.4%	8,285 $1.43 Million
Q1 2023 Apr 17, 2023	SELL	$145.48 - $175.02 $66,775 - $80,334	-459 Reduced 5.32%	8,171 $1.36 Million
Q4 2022 Jan 25, 2023	BUY	$131.14 - $157.47 $47,472 - $57,004	362 Added 4.38%	8,630 $1.27 Million
Q3 2022 Oct 24, 2022	BUY	$148.29 - $182.55 $65,099 - $80,139	439 Added 5.61%	8,268 $1.23 Million
Q2 2022 Aug 10, 2022	BUY	$155.97 - $200.09 $67,690 - $86,839	434 Added 5.87%	7,829 $1.35 Million
Q4 2021 Feb 02, 2022	BUY	$193.69 - $247.03 $35,832 - $45,700	185 Added 2.57%	7,395 $1.81 Million
Q3 2021 Oct 18, 2021	BUY	$189.29 - $209.69 $45,051 - $49,906	238 Added 3.41%	7,210 $1.4 Million
Q2 2021 Aug 06, 2021	BUY	$155.9 - $187.99 $10,913 - $13,159	70 Added 1.01%	6,972 $1.3 Million
Q1 2021 Apr 27, 2021	SELL	$144.0 - $169.39 $1,584 - $1,863	-11 Reduced 0.16%	6,902 $1.09 Million
Q4 2020 Jan 15, 2021	BUY	$157.07 - $174.35 $79,006 - $87,698	503 Added 7.85%	6,913 $1.14 Million
Q3 2020 Oct 09, 2020	BUY	$137.1 - $165.37 $4,387 - $5,291	32 Added 0.5%	6,410 $1.06 Million
Q2 2020 Jul 08, 2020	SELL	$111.92 - $142.53 $19,474 - $24,800	-174 Reduced 2.66%	6,378 $874,000
Q1 2020 Apr 24, 2020	BUY	$92.66 - $144.94 $53,094 - $83,050	573 Added 9.58%	6,552 $771,000
Q4 2019 Jan 22, 2020	SELL	$116.25 - $133.25 $42,896 - $49,169	-369 Reduced 5.81%	5,979 $828,000
Q3 2019 Oct 23, 2019	BUY	$112.57 - $128.43 $54,596 - $62,288	485 Added 8.27%	6,348 $791,000
Q2 2019 Aug 02, 2019	BUY	$97.98 - $114.28 $301,288 - $351,411	3,075 Added 110.29%	5,863 $665,000
Q1 2019 May 14, 2019	BUY	$81.56 - $100.67 $227,389 - $280,667	2,788 New	2,788 $281,000

Others Institutions Holding ZTS

# of Institutions

1,957

Shares Held

410M

Call Options Held

1.02M

Put Options Held

1.09M

View Full List

About Zoetis Inc.

Ticker ZTS
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 468,139,008
Market Cap $77.1B
Description
Zoetis Inc. discovers, develops, manufactures, and commercializes animal health medicines, vaccines, and diagnostic products in the United States and internationally. It commercializes products primarily across species, including livestock, such as cattle, swine, poultry, fish, and sheep; and companion animals comprising dogs, cats, and horses. ...

More about ZTS

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Clarius Group, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Clarius Group, LLC with notifications on news.

Account

Clarius Group, LLC Zoetis Inc. Transaction History